THCA (tetrahydrocannabinolic acid, systematic name: (−)-Δ⁹-trans-tetrahydrocannabinolic acid A) is a naturally occurring phytocannabinoid synthesised in the trichomes of Cannabis sativa L. It is produced when the precursor cannabigerolic acid (CBGA) is enzymatically converted by THCA synthase, and it accumulates as the dominant cannabinoid in fresh or undried plant material. Because THCA carries a carboxyl group (–COOH) attached to its aromatic ring, it does not cross the blood–brain barrier efficiently and does not bind meaningfully to CB1 or CB2 receptors at physiological concentrations , the interaction profile that underlies THC's psychoactive effects is therefore absent in THCA.
Decarboxylation , the irreversible loss of that carboxyl group as CO₂ , converts THCA into THC. This reaction occurs slowly at ambient temperature over time, and rapidly when cannabis material is heated above approximately 105 °C, as happens during smoking, vaporising, or cooking. The extent of decarboxylation in any given preparation directly determines how much THC is present and, consequently, whether the material is psychoactive.
Preclinical research has examined THCA's molecular interactions, including preliminary evidence of activity at TRPA1 and TRPM8 ion channels and possible influence on PPARγ receptors; however, these findings come predominantly from in vitro and animal studies. Human clinical data remain limited, and no established therapeutic role has been confirmed for THCA by the Therapeutic Goods Administration (TGA) or comparable international regulators. Under the Poisons Standard (the SUSMP), THCA derived from cannabis is subject to the same scheduling controls as other cannabis-derived substances; Schedule 4 (prescription-only medicine) or Schedule 8 (controlled drug) depending on concentration and form, and any medicinal cannabis product supplied in Australia must hold TGA approval or be accessed through the Special Access Scheme (SAS) or Authorised Prescriber pathway.
Analytical quantification of THCA is a standard component of cannabis potency testing, with high-performance liquid chromatography (HPLC) preferred over gas chromatography (GC) because GC conditions induce decarboxylation and therefore overestimate THC content. Reported THCA concentrations in dried flower preparations vary considerably across cultivars and growing conditions.
Sources:
- Moreno-Sanz G. (2016). Can You Pass the Acid Test? Critical Review and Novel Therapeutic Perspectives of Δ9-Tetrahydrocannabinolic Acid A, Cannabis and Cannabinoid Research, NCBI/NLM
- Guidance on access to medicinal cannabis products; Therapeutic Goods Administration (TGA)
- Stasiłowicz A. et al. (2021). Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment, NCBI/NLM Bookshelf